- Home
- /
- News
- /
- Novel Technologies
- /
- October 2013
Novel Technologies News for October 2013
Ablynx today announced that its partner Boehringer Ingelheim has dosed the first healthy volunteers in a Phase I clinical trial as part of the evaluation of a Nanobody® for the treatment of Alzheimer’s disease. The start of the Phase I study triggers a milestone payment of €5 million to Ablynx.
29 October, 2013
A living cell is built with barriers to keep things out – and researchers are constantly trying to find ways to smuggle molecules in. ?Professor Giovanni Maglia (Biochemistry, Molecular and Structural Biology, KU Leuven) and his team have engineered a biological nanopore that acts as a selective revolving door through a cell’s lipid membrane. The nanopore could potentially be used in gene therapy and targeted drug delivery.
24 October, 2013
CPhI announces exhibitors latest product news and Awards finalists ahead of showCPhI Pharma Award Finalists.Best Innovation in Process DevelopmentAPI Corporation: A novel and practical synthesis of highly functionalized pharmaceuticals through C-H activation;Bachem: Pioneering breakthrough in the chemical synthesis of Interferon ß-1a;Codexis: Enzymes for Green and Scalable Biocatalytic OxidationsBest Innovation in FormulationBitop: Ectoin - a new natural ingredient with proven efficacy;Camurus: FluidCrystal Injection depotEmulTech: Microfluidic platform for controlled development;Best Innovation in PackagingE-Pharma Trento: E-PHARMA TRENTO SpA;Doctor Pack India: MAGIC CAP;Neutroplast: Vaginal applicator
18 October, 2013
The whisky and salmon industries in Scotland are about to embark on an innovative new partnership which will convert waste from whisky production into feed for salmon and fish farming.
04 October, 2013
Over 40% of exhibitors at Lab Innovations 2013, which returns to Birmingham’s NEC on 6 & 7 November, are using the show to launch new technologies and services into the UK. Here is a brief first overview of just some of the products debuting at the show.
03 October, 2013
Cancer researchers are not shy of using nanotechnology. Their work is making promising headway into developing safer and more effective treatments.
02 October, 2013
The BioIndustry Association (BIA) and UK Trade and Investment (UKTI) today announce the nine leading UK companies that will showcase UK expertise in synthetic biology (synbio) at SynBioBeta SF 2013, a key global synbio start-up conference taking place in California in November.
01 October, 2013